Multiple-dose pharmacokinetics of fluvoxamine in children and adolescents

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 43, Issue 12, 2004, Pages 1497-1505

  Labellarte, Michael ^a,g   Biederman, Joseph ^b   Emslie, Graham ^c   Ferguson, James ^d   Khan, Arifulla ^e   Ruckle, Jon ^d   Sallee, Randy ^f   Riddle, Mark ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

^d RADIANT RESEARCH   (United States)

^e Northwest Clinical Research Center   (United States)

^f UNIVERSITY OF CINCINNATI   (United States)

^g CMSC 340 ^*  (United States)

Author keywords

Anxiety disorders; Fluvoxamine; Pediatric; Pharmacokinetics

Indexed keywords

FLUVOXAMINE; ANXIOLYTIC AGENT; CYTOCHROME P450 2D6;

ABDOMINAL PAIN; ADOLESCENT; AREA UNDER THE CURVE; ARTICLE; ASTHENIA; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIZZINESS; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CLEARANCE; FEMALE; HEADACHE; HUMAN; HYPOMANIA; INFECTION; INSOMNIA; MALE; MULTIPLE DRUG DOSE; NAUSEA; NERVOUSNESS; OBSESSIVE COMPULSIVE DISORDER; PAIN; PHARYNGITIS; PRIORITY JOURNAL; RHINITIS; SIDE EFFECT; SOMNOLENCE; ANXIETY DISORDER; BLOOD; DRUG ADMINISTRATION; METABOLISM;

ADOLESCENT; ANTI-ANXIETY AGENTS; ANXIETY DISORDERS; CHILD; CYTOCHROME P-450 CYP2D6; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUVOXAMINE; HUMANS; MALE; OBSESSIVE-COMPULSIVE DISORDER;

EID: 16344395010     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.chi.0000143546.28821.11     Document Type: Article

References (15)

1. Alderman J, Wolkow R, Chung M, Johnston HF (1998), Sertraline treatment of children and adolescents with obsessive-compulsive disorder or depression: pharmacokinetics, tolerability and efficacy. J Am Acad Child Adolesc Psychiatry 37:386-394
2. American Psychiatric Association (1994), Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV). Washington, DC: American Psychiatric Press
3. Carlsson B, Olsson G, Reis M et al. (2001), Enantioselective analysis of citalopram and metabolites in adolescents. Ther Drug Monit 23:658-664
4. Coffey B, Shader RI, Greenblatt DJ (1983), Pharmacokinetics of benzodiazepines and psychostimulants in children. J Clin Psychopharmacol 3:217-225
5. Findling RL, Preskorn SH, Marcus RN et al. (2000), Nefazodone pharmacokinetics in depressed children and adolescents. J Am Acad Child Adolesc Psychiatry 39:1008-1016
6. Findling RL, Reed MD, Myers C et al. (1999), Paroxetine pharmacokinetics in depressed children and adolescents. J Am Acad Child Adolesc Psychiatry 38:952-959
7. Hartter S, Wetzel H, Hammes E, Torkczadeh M, Hiemke C (1998), Nonlinear pharmacokinetics of fluvoxamine and gender differences. Ther Drug Monit 20:446-449
8. Persico AM, Militerni R, Bravaccio C et al. (2000), Lack of association between serotonin transporter gene promoter variants and autistic disorder in two ethnically distinct samples. Am J Med Genet 96:123-127
9. Research Units on Pediatric Psychopharmacology Anxiety Study Group (2001), Fluvoxamine for the treatment of anxiety disorders in children and adolescents. N Engl J Med 344:1279-1285
10. Research Units on Pediatric Psychopharmacology Anxiety Study Group (2003), Searching for moderators and mediators of pharmacological treatment effects in children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry 42:13-21
11. Riddle MA, Reeve EA, Yaryura-Tobias JA et al. (2001), Fluvoxamine for children and adolescents with obsessive compulsive disorder: a controlled multicenter trial. J Am Acad Child Adolesc Psychiatry 40:222-229
12. Salazar DE, Frackiewicz EJ, Dockens R et al. (2001), Pharmacokinetics and tolerability of buspirone during oral administration to children and adolescents with anxiety disorder and normal healthy adults. J Clin Pharmacol 41:1351-1358
13. Spigset O, Granberg K, Hagg S, Sodetstrom E, Dahlqvist R (1998), Nonlinear fluvoxamine disposition. Br J Pharmacol 45:257-263
14. Tanner JM (1969), Growth and endocrinology of the adolescent. In: Endocrine and Genetic Diseases of Childhood, Gardner L, ed. Philadelphia: Saunders
15. Wilens TE, Cohen L, Biederman J et al. (2002), Fluoxetine pharmacokinetics in pediatric patients. J Clin Psychopharmacol 22:568-575